What does Dr. Sarah Vromman do?

Dr. Sarah Vromman is a general practice in Roeselare. Private Limited, started on 1 April 2022, 1 establishment.

What is the address of Dr. Sarah Vromman?

The registered office of Dr. Sarah Vromman is located at Duivelsstraat 11, 8800 Roeselare.

Is Dr. Sarah Vromman still active?

Yes. According to the CBE (2 October 2026) Dr. Sarah Vromman is active, legal situation “Normale toestand”, started on 1 April 2022.

Is Dr. Sarah Vromman registered on Peppol?

Yes, Dr. Sarah Vromman is registered on the Peppol network with ID 0208:0784381887.

What is the enterprise number of Dr. Sarah Vromman?

The enterprise number of Dr. Sarah Vromman is BE0784381887.

When was Dr. Sarah Vromman founded?

Dr. Sarah Vromman was founded on 1 April 2022.

Who are the directors of Dr. Sarah Vromman?

According to the 2025 annual accounts, the directors of Dr. Sarah Vromman are: Sarah Vromman.

Is Dr. Sarah Vromman a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 1 April 2022; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dr. Sarah Vromman make in 2025?

Dr. Sarah Vromman posted a profit after taxes of € 90,859 in financial year 2025.

What is the revenue of Dr. Sarah Vromman?

As a small company, Dr. Sarah Vromman is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 139,576.

Dr. Sarah Vromman (Private Limited) - Roeselare

Dossier Dr. Sarah Vromman, printed on 2 October 2026 from databakkes.be/en/0784381887/dr-sarah-vromman. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dr. Sarah Vromman from Roeselare, company number BE0784381887, closed financial year 2025 with a result of € 90,859 after tax. For that financial year Dr. Sarah Vromman recorded a gross margin of € 139,576 and equity of € 93,859. Compared with financial year 2024, the result moved from € 73,416 to € 90,859. Profitable, and profit is growing. The buffer shrank hard: equity is 62 % below last year. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2026.

What it is worth Shrank hard

€ 93,859

▼ 62% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 90,859

▲ 24% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 45,513

▼ 74% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 245,303 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 172

▲ € 170 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 2,557

▲ 2% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 125,032 Gross margin 2022: € 125,032 First fiscal year in the series	€ 130,118 Gross margin 2023: € 130,118 ▲ 4% vs 2022 (€ 125,032) Favourable step	€ 117,878 Gross margin 2024: € 117,878 ▼ 9% vs 2023 (€ 130,118) Unfavourable step	€ 139,576 Gross margin 2025: € 139,576 ▲ 18% vs 2024 (€ 117,878) Favourable step	▲ 18%
Profit after taxes	€ 88,176 Profit after taxes 2022: € 88,176 First fiscal year in the series	€ 83,710 Profit after taxes 2023: € 83,710 ▼ 5% vs 2022 (€ 88,176) Unfavourable step	€ 73,416 Profit after taxes 2024: € 73,416 ▼ 12% vs 2023 (€ 83,710) Unfavourable step	€ 90,859 Profit after taxes 2025: € 90,859 ▲ 24% vs 2024 (€ 73,416) Favourable step	▲ 24%
Equity	€ 91,176 Equity 2022: € 91,176 First fiscal year in the series	€ 174,886 Equity 2023: € 174,886 ▲ 92% vs 2022 (€ 91,176) Favourable step	€ 248,303 Equity 2024: € 248,303 ▲ 42% vs 2023 (€ 174,886) Favourable step	€ 93,859 Equity 2025: € 93,859 ▼ 62% vs 2024 (€ 248,303) Unfavourable step	▼ 62%
Total debts	€ 214,941 Total debts 2022: € 214,941 First fiscal year in the series	€ 115,400 Total debts 2023: € 115,400 ▼ 46% vs 2022 (€ 214,941) Favourable step	€ 123,399 Total debts 2024: € 123,399 ▲ 7% vs 2023 (€ 115,400) Unfavourable step	€ 155,875 Total debts 2025: € 155,875 ▲ 26% vs 2024 (€ 123,399) Unfavourable step	▲ 26%
Cash	€ 72,521 Cash 2022: € 72,521 First fiscal year in the series	€ 89,511 Cash 2023: € 89,511 ▲ 23% vs 2022 (€ 72,521) Favourable step	€ 175,919 Cash 2024: € 175,919 ▲ 97% vs 2023 (€ 89,511) Favourable step	€ 45,513 Cash 2025: € 45,513 ▼ 74% vs 2024 (€ 175,919) Unfavourable step	▼ 74%
Retained profit	€ 88,176 Retained profit 2022: € 88,176 First fiscal year in the series	€ 171,886 Retained profit 2023: € 171,886 ▲ 95% vs 2022 (€ 88,176) Favourable step	€ 245,303 Retained profit 2024: € 245,303 ▲ 43% vs 2023 (€ 171,886) Favourable step	€ 90,859 Retained profit 2025: € 90,859 ▼ 63% vs 2024 (€ 245,303) Unfavourable step	▼ 63%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 245,303 Dividend 2025: € 245,303 Unchanged (€ 0) Unchanged
Balance sheet total	€ 306,117 Balance sheet total 2022: € 306,117 First fiscal year in the series	€ 290,287 Balance sheet total 2023: € 290,287 ▼ 5% vs 2022 (€ 306,117) Unchanged	€ 371,702 Balance sheet total 2024: € 371,702 ▲ 28% vs 2023 (€ 290,287) Unchanged	€ 249,733 Balance sheet total 2025: € 249,733 ▼ 33% vs 2024 (€ 371,702) Unchanged	▼ 33%

Key figures of Dr. Sarah Vromman, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. Sarah Vromman?

What happened at Dr. Sarah Vromman in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 31, 2026 New annual accounts for financial year 2025: profit of € 90,859 (▲ 24% vs 2024). filed late Source: NBB ↗
Apr 1, 2022 New establishment in Ardooie. KBO
2022 Sarah Vromman became a director. NBB
Apr 1, 2022 Start of the company according to the CBE. KBO

In short

From € 88,176 profit in 2022 to € 90,859 profit in 2025.

Paid € 88,466 in corporate taxes since 2022.

Best year ever: 2025, with € 90,859 profit.

Paid out € 245,303 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. Sarah Vromman? We notify you, reason included.

Follow Dr. Sarah Vromman

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Sarah Vromman

Dr. Sarah Vromman

Behind Dr. Sarah Vromman is Sarah Vromman.

See the full network in the app

Directors

According to the 2025 annual accounts

Sarah Vromman

Director

since 2022

Establishments

Establishment units

Physical locations of this company

Registered office

Duivelsstraat 11

8800 Roeselare

2.330.049.272

Hoflandstraat 12

8850 Ardooie

Active since 1 April 2022

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0784.381.887
VAT number: BE 0784.381.887
Registered office: Duivelsstraat 11, 8800 Roeselare
Names & denominations: Dr. Sarah Vromman
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 1 April 2022
Peppol: Active · Active since 28 Jan 2026
Contact: [email protected]
Activities · NACE: Activiteiten van huisartspraktijken

View on CBE Public ↗ Annual accounts (NBB) ↗